Next generation sequencing: Coping with rare genetic diseases in China

Intractable and Rare Diseases Research

Volumn 5, Issue 3, 2016, Pages 140-144

  Cram, David S ^a,b   Zhou, Daixing ^a  

^a Berry Genomics   (China)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Chromosome disease; Monogenic disease; Next generation sequencing (NGS); Noninvasive prenatal testing (NIPT); Whole exome sequencing (WES)

Indexed keywords

ARTICLE; CHINA; COPING BEHAVIOR; GENETIC DISORDER; GENETIC SCREENING; GOVERNMENT; HUMAN; NEXT GENERATION SEQUENCING; NON INVASIVE PROCEDURE; PATIENT CARE; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; RARE DISEASE; REGISTER;

EID: 85030146363     PISSN: 21863644     EISSN: 2186361X     Source Type: Journal    
DOI: 10.5582/irdr.2016.01020     Document Type: Article

References (24)

1. Bankier A, Cram DS. Genetic testing: An informed choice. In: The Sorting Society: Ethics of Genetic Testing and Therapy (Thompson J, Skene L, eds.). Cambridge University Press, London, UK, 2008; pp.7-20.
2. Boycott KM, Vanstone MR, Bulman DE, MacKenzie AE. Rare-disease genetics in the era of next-generation sequencing: Discovery to translation. Nat Rev Genet. 2013; 14:681-691.
3. Wang JB, Guo JJ, Yang L, Zhang YD, Sun ZQ, Zhang YJ. Rare disease and legislation in China. Lancet. 2010; 3759716:708-709.
4. Demaliaj E, Cerekja A, Piazze J. Sex chromosome aneuploidies. aneuploidy in health and disease. In: Aneuploidy in health and disease (Storchova Z, eds.). InTech, Shanghai, China, 2012; pp.123-140.
5. Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012; 367:2175-2184.
6. Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of a and βthalassaemia in Guangdong Province: Implications for the future health burden and population screening. J Clin Pathol. 2004; 57:517-522.
7. Xiong F, Sun M, Zhang X, Cai R, Zhou Y, Lou J, Zeng L, Sun Q, Xiao Q, Shang X, Wei X, Zhang T, Chen P, Xu X. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet. 2010; 78:139-148.
8. Zhang YJ, Wang YO, Li L, Guo JJ, Wang JB. China's first rare-disease registry is under development. Lancet. 2011; 378:769-770.
9. Liao C, Mo QH, Li J, Li LY, Huang YN, Hua L, Li QM, Zhang JZ, Feng Q, Zeng R, Zhong HZ, Jia SQ, Cui YY, Xu XM. Carrier screening for alpha-and beta-thalassemia in pregnancy: The results of an 11-year prospective program in Guangzhou Maternal and Neonatal hospital. Prenat Diagn. 2005; 25:163-171.
10. An N, Li LL, Wang RX, Li LL, Yue JM, Liu RZ. Clinical and cytogenetic results of a series of amniocentesis cases from Northeast China: A report of 2500 cases. Genet Mol Res. 2015; 14:15660-15667.
11. Chopra M, Duan T. Rare genetic disease in China: A call to improve clinical services. Orphanet J Rare Dis. 2015; 10:140.
12. Lohmann K, Klein C. Next generation sequencing and the future of genetic diagnosis. Neurotherapeutics. 2014; 11:699-707.
13. Liang D, Lv W, Wang H, Xu L, Liu J, Li H, Hu L, Peng Y, Wu L. Non-invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing. Prenat Diag. 2013; 33:409-415.
14. Song Y, Liu C, Qi H, Zhang Y, Bian X, Liu J. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population. Prenat Diagn. 2013; 33:700-706.
15. Yang Y, Muzny DM, Reid JG, et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med. 2013; 369:1502-1511.
16. Berger VK, Baker VL. Preimplantation diagnosis for single gene disorders. Semin Reprod Med. 2014; 32:107-113.
17. Madrigal I, Alvarez-Mora MI, Karlberg O, Rodríguez-Revenga L, Elurbe DM, Rabionet R, Mur A, Pie J, Ballesta F, Sauer S, Syvänen AC, Milà M. Efficient application of next-generation sequencing for the diagnosis of rare genetic syndromes. J Clin Pathol. 2014; 67:1099-1103.
18. Grody WW, Thompson BH, Hudgins L. Whole-exome/genome sequencing and genomics. Pediatrics. 2013; 132(Suppl 3):S211-S215.
19. Rabbani B, Mahdieh N, Hosomichi K, Nakaoka H, Inoue I. Next-generation sequencing: Impact of exome sequencing in characterizing Mendelian disorders. J Hum Genet. 2012; 57:621-632.
20. Wei Q, Zhu H, Qian X, Chen Z, Yao J, Lu Y, Cao X, Xing G. Targeted genomic capture and massively parallel sequencing to identify novel variants causing Chinese hereditary hearing loss. J Transl Med. 2014; 12:311.
21. Yin AH, Peng CF, Zhao X, et al. Noninvasive detection of fetal submicroscopic abnormalities by semiconductor sequencing of maternal plasma DNA. Proc Natl Acad Sci U S A. 2015; 112:14670-14675.
22. Meng M, Li X, Ge H, et al. Noninvasive prenatal testing for autosomal recessive conditions by maternal plasma sequencing in a case of congenital deafness. Genet Med. 2014; 16:972-976.
23. Chen M, Lu S, Lai Z, Chen C, Luo K, Yuan Y, Wang Y, Li S, Gao Y, Chen F, Asan, Chen D. Targeted sequencing of maternal plasma for haplotype-based noninvasive prenatal diagnosis testing of spinal muscular atrophy. Ultrasound Obstet Gynecol. 2016. Doi: 10.1002/uog. 15947.
24. Lv W, Wei X, Guo R, Liu Q, Zheng Y, Chang J, Bai T, Li H, Zhang J, Song Z, Cram DS, Liang D, Wu L. Noninvasive prenatal testing for Wilson disease by use of circulating single-molecule amplification and resequencing technology (cSMART). Clin Chem. 2015; 61:172-181.